FDA rejects Disc's rare disease drug despite commissioner's voucher Read more
'It's really a dire time for patients': Biohaven CEO says FDA red tape is blocking access to rare disease treatments Read more
After R&D head exits, Immunocore CEO pairs ambition with caution for growing cancer portfolio Read more
April 28, 2025 @ 1:30 pm - April 30, 2025 @ 4:00 pm

The LSX World Congress is Europe’s premier event for life science leaders, designed to connect senior decision-makers from biopharma, medtech, and healthtech sectors. It offers invaluable opportunities to share best practices, forge strategic partnerships, and discuss investment, all aimed at revolutionising healthcare.
This event brings together key players across the life sciences ecosystem, including investors, R&D leaders, senior BD&L teams, and industry KOLs. Attendees can engage in qualified 1:1 partnering, hear from 250+ expert speakers, and access case studies and discussions on cutting-edge industry strategies.